Nanovibronix (FEED) & Its Competitors Head to Head Review

Nanovibronix (NASDAQ:FEED) is one of 29 publicly-traded companies in the “Surgical, Medical, And Dental Instruments And Supplies” industry, but how does it compare to its peers? We will compare Nanovibronix to similar businesses based on the strength of its risk, institutional ownership, profitability, dividends, earnings, analyst recommendations and valuation.

Volatility & Risk

Nanovibronix has a beta of 2.21, indicating that its stock price is 121% more volatile than the S&P 500. Comparatively, Nanovibronix’s peers have a beta of 1.76, indicating that their average stock price is 76% more volatile than the S&P 500.

Earnings & Valuation

This table compares Nanovibronix and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Nanovibronix	$2.56 million	-$3.70 million	-0.07
Nanovibronix Competitors	$59.54 million	-$32.15 million	4.18

Nanovibronix’s peers have higher revenue, but lower earnings than Nanovibronix. Nanovibronix is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Nanovibronix and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-275.12%	-24.78%	-19.24%
Nanovibronix Competitors	-672.41%	-133.75%	-59.01%

Analyst Ratings

This is a summary of current ratings and recommmendations for Nanovibronix and its peers, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1	0	0	0	1.00
Nanovibronix Competitors	77	76	156	6	2.29

As a group, “Surgical, Medical, And Dental Instruments And Supplies” companies have a potential upside of 51.09%. Given Nanovibronix’s peers stronger consensus rating and higher probable upside, analysts clearly believe Nanovibronix has less favorable growth aspects than its peers.

Insider and Institutional Ownership

16.4% of Nanovibronix shares are owned by institutional investors. Comparatively, 22.5% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are owned by institutional investors. 5.2% of Nanovibronix shares are owned by insiders. Comparatively, 18.4% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Nanovibronix peers beat Nanovibronix on 7 of the 12 factors compared.

Nanovibronix Company Profile

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.